Long‐term outcomes after stent implantation in very small vessel coronary artery disease
Clinical Cardiology · 2023
DOI: 10.1002/clc.24000 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Cardiology, 2023. Verfasst von En-Shao Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Medical Center, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Drug-Eluting Stents, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Percutaneous coronary interventions (PCI) in very small vessel lesions represent an intriguing aspect of coronary artery disease (CAD). Uncertainty still exists in stent implantation in very small caliber vessels. This study aimed to evaluate the long‐term outcomes of patients treated with 2.0‐mm drug‐eluting stent (DES).
Method
This retrospective observational study included 134 patients undergoing PCI with 2.0‐mm zotarolimus DES from December 2016 to May 2020. The primary endpoint was major adverse cardiovascular events (MACE) at 2‐year follow‐up, which was composed of all‐cause mortality, target vessel myocardial infarction, and ischemia‐driven target lesion revascularization. Multiple logistic regression analysis was used to identify the independent predictors of MACE, and odds ratios (OR) and 95% confidence intervals (CI) were calculated.
Result
The lesions were diffuse (mean length 20.9 ± 5.51 mm) and belong to type B2/C lesions (90.3%). On follow‐up, the MACE rate was 20.1% and mostly driven by late lumen loss demanding revascularization (11.9%). In multivariable analysis, chronic kidney disease (CKD) (OR: 4.291, 95% CI: 1.574−11.704, p = 0.004) and calcified lesions (OR: 3.688, 95% CI: 1.311−10.371, p = 0.013) were the independent predictors of subsequent cardiovascular events, whereas statin was associated with better outcomes (OR: 0.335, 95% CI: 0.119−0.949, p = 0.040).
Conclusion
2.0‐mm DES is a feasible option for treating very small vessel CAD in complex lesions. Patients with CKD and calcified lesions carry the hazard of worse outcomes, and careful consideration should be taken before stenting in this high‐risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Medical Center, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Cardiology, Kaohsiung Municipal United Hospital, Kaohsiung, Taiwan.
- Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Physical Therapy, Fooyin University, Kaohsiung, Taiwan.
Zitieren
APA
Liu, E. S., Yang, T. H., Tai, T. H., Chiang, C. H., Cheng, C. C., Huang, W. C., Mar, G. Y., & Kuo, F. Y. (2023). Long‐term outcomes after stent implantation in very small vessel coronary artery disease. Clinical Cardiology. https://doi.org/10.1002/clc.24000
Vancouver
Liu ES, Yang TH, Tai TH, Chiang CH, Cheng CC, Huang WC, et al. Long‐term outcomes after stent implantation in very small vessel coronary artery disease. Clinical Cardiology. 2023. doi:10.1002/clc.24000
BibTeX
@article{Liu2023,
author = {Liu, En-Shao and Yang, Tse-Hsuan and Tai, Ta-Hsin and Chiang, Cheng-Hung and Cheng, Chin-Chang and Huang, Wei-Chun and Mar, Guang-Yuan and Kuo, Feng-Yu},
title = {Long‐term outcomes after stent implantation in very small vessel coronary artery disease},
journal = {Clinical Cardiology},
year = {2023},
doi = {10.1002/clc.24000}
}
EUVIMED